Kim, J.-E.; Park, H.; Jeong, M.-J.; Kang, T.-C.
Epigallocatechin-3-Gallate and PEDF 335 Peptide, 67LR Activators, Attenuate Vasogenic Edema, and Astroglial Degeneration Following Status Epilepticus. Antioxidants 2020, 9, 854.
https://doi.org/10.3390/antiox9090854
AMA Style
Kim J-E, Park H, Jeong M-J, Kang T-C.
Epigallocatechin-3-Gallate and PEDF 335 Peptide, 67LR Activators, Attenuate Vasogenic Edema, and Astroglial Degeneration Following Status Epilepticus. Antioxidants. 2020; 9(9):854.
https://doi.org/10.3390/antiox9090854
Chicago/Turabian Style
Kim, Ji-Eun, Hana Park, Min-Jeong Jeong, and Tae-Cheon Kang.
2020. "Epigallocatechin-3-Gallate and PEDF 335 Peptide, 67LR Activators, Attenuate Vasogenic Edema, and Astroglial Degeneration Following Status Epilepticus" Antioxidants 9, no. 9: 854.
https://doi.org/10.3390/antiox9090854
APA Style
Kim, J.-E., Park, H., Jeong, M.-J., & Kang, T.-C.
(2020). Epigallocatechin-3-Gallate and PEDF 335 Peptide, 67LR Activators, Attenuate Vasogenic Edema, and Astroglial Degeneration Following Status Epilepticus. Antioxidants, 9(9), 854.
https://doi.org/10.3390/antiox9090854